Showing 1 - 10 results of 10 for search 'Matthew J Loza', query time: 0.05s
Refine Results
-
1
-
2
Assembly of inflammation-related genes for pathway-focused genetic analysis. by Matthew J Loza, Charles E McCall, Liwu Li, William B Isaacs, Jianfeng Xu, Bao-Li Chang
Published 2007-10-01
Article -
3
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials by Kristen Sweet, Matthew J Loza, Philip Cooper, Qingxuan Song, Keying Ma, Karen Leander, Vani Lakshminarayanan, Carol Franks
Published 2021-08-01
Article -
4
-
5
I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. by Stelios Pavlidis, Calixte Monast, Matthew J Loza, Patrick Branigan, Kiang F Chung, Ian M Adcock, Yike Guo, Anthony Rowe, Frédéric Baribaud
Published 2019-04-01
Article -
6
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study by Lydia J. Finney, Stefan Avey, Dexter Wiseman, Anthony Rowe, Matthew J. Loza, Patrick Branigan, Christopher S. Stevenson, Frédéric Baribaud, Jadwiga A. Wedzicha, Ioannis Pandis, Gavin C. Donaldson
Published 2023-12-01
Article -
7
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab by Kim Thys, Matthew J. Loza, Linghua Lynn, Katleen Callewaert, Lisa Varma, Marjolein Crabbe, Liesbeth Van Wesenbeeck, Erika Van Landuyt, Sandra De Meyer, Jeroen Aerssens, Inge Verbrugge
Published 2024-10-01
Article -
8
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. by Carl L Manthey, Beverley A Moore, Yanqing Chen, Matthew J Loza, Xiang Yao, Hao Liu, Stanley M Belkowski, Holly Raymond-Parks, Paul J Dunford, Francisco Leon, Jennifer E Towne, Scott E Plevy
Published 2019-01-01
Article -
9
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation by Philip E Silkoff, Dave Singh, J Mark FitzGerald, Andreas Eich, Andrea Ludwig-Sengpiel, Geoffrey C Chupp, Vibeke Backer, Celeste Porsbjerg, Pierre-Olivier Girodet, Mark T Dransfield, Frederic Baribaud, Vedrana S Susulic, Matthew J Loza
Published 2017-09-01
Article -
10
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: resul... by Kaiyin Fei, Peter C Taylor, Tom WJ Huizinga, Georg Schett, Matthew J Loza, Chetan S Karyekar, Bei Zhou, Jocelyn H Leu, Qingmin Wang, Keying Ma, Fowzia Ibrahim, Yuan Xiong, Sheng Gao, Sophia G Liva, Jafar Sadik B Shaik, Rohit A Panchakshari, Harman Dhatt, Ricardo Rojo Cella, Carolyn A Cuff
Published 2024-05-01
Article